Growth differentiation factor 15 (GDF-15) polypeptides
US9714276B2 · kind B2 · utility
15Cited by
5References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 28, 2013 |
| Grant date | Jul 25, 2017 |
| Priority date | — |
| Expiry date | May 6, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
GDF15 polypeptides, constructs comprising GDF15, and mutants thereof are provided. In various embodiments the GDF15 polypeptides, constructs comprising GDF15, and mutants thereof, can be of use in the treatment or ameliorating a metabolic disorder. In various embodiments the metabolic disease or disorder is type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels and diabetic nephropathy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.